Concepts (60)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Vitiligo | 6 | 2022 | 120 | 1.310 |
Why?
|
| Hypopigmentation | 1 | 2022 | 17 | 0.790 |
Why?
|
| T-Lymphocytes, Regulatory | 3 | 2022 | 196 | 0.480 |
Why?
|
| Melanocytes | 3 | 2022 | 78 | 0.360 |
Why?
|
| Skin | 3 | 2022 | 351 | 0.320 |
Why?
|
| Chemokines | 2 | 2019 | 94 | 0.290 |
Why?
|
| Receptors, CCR6 | 1 | 2022 | 10 | 0.200 |
Why?
|
| RNA, Small Cytoplasmic | 1 | 2021 | 6 | 0.190 |
Why?
|
| Receptors, CCR5 | 1 | 2021 | 57 | 0.190 |
Why?
|
| Immunologic Memory | 2 | 2020 | 276 | 0.170 |
Why?
|
| Skin Diseases | 1 | 2019 | 74 | 0.150 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2019 | 236 | 0.150 |
Why?
|
| Disease Models, Animal | 2 | 2022 | 2062 | 0.140 |
Why?
|
| Autoimmune Diseases | 1 | 2019 | 222 | 0.140 |
Why?
|
| Immunotherapy | 1 | 2019 | 229 | 0.140 |
Why?
|
| Epidermis | 1 | 2016 | 37 | 0.140 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2018 | 646 | 0.130 |
Why?
|
| Simvastatin | 1 | 2014 | 28 | 0.120 |
Why?
|
| Skin Pigmentation | 1 | 2014 | 32 | 0.120 |
Why?
|
| Mice | 4 | 2022 | 10259 | 0.120 |
Why?
|
| Animals | 7 | 2022 | 19614 | 0.120 |
Why?
|
| T-Lymphocytes | 1 | 2016 | 963 | 0.100 |
Why?
|
| Totipotent Stem Cells | 1 | 2009 | 4 | 0.090 |
Why?
|
| Aptamers, Nucleotide | 1 | 2009 | 18 | 0.080 |
Why?
|
| RNA-Binding Proteins | 1 | 2009 | 384 | 0.070 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2009 | 630 | 0.060 |
Why?
|
| Chemokine CXCL10 | 2 | 2016 | 60 | 0.060 |
Why?
|
| Humans | 6 | 2022 | 59339 | 0.060 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 2009 | 396 | 0.060 |
Why?
|
| Cell Differentiation | 1 | 2009 | 1295 | 0.060 |
Why?
|
| Interferon-gamma | 2 | 2016 | 539 | 0.050 |
Why?
|
| Cytokines | 2 | 2020 | 906 | 0.050 |
Why?
|
| Mice, Transgenic | 2 | 2018 | 1221 | 0.050 |
Why?
|
| Biomarkers | 2 | 2020 | 1206 | 0.050 |
Why?
|
| Single-Cell Analysis | 1 | 2021 | 83 | 0.050 |
Why?
|
| Disease Susceptibility | 1 | 2020 | 158 | 0.040 |
Why?
|
| Molecular Targeted Therapy | 1 | 2019 | 118 | 0.040 |
Why?
|
| Immunity, Cellular | 1 | 2019 | 176 | 0.040 |
Why?
|
| Autoimmunity | 1 | 2020 | 223 | 0.040 |
Why?
|
| Disease Management | 1 | 2020 | 220 | 0.040 |
Why?
|
| Cell Movement | 1 | 2019 | 422 | 0.040 |
Why?
|
| Signal Transduction | 2 | 2019 | 2890 | 0.030 |
Why?
|
| Chemokine CXCL9 | 1 | 2016 | 24 | 0.030 |
Why?
|
| Flow Cytometry | 1 | 2018 | 671 | 0.030 |
Why?
|
| Keratinocytes | 1 | 2016 | 63 | 0.030 |
Why?
|
| Pigmentation | 1 | 2014 | 25 | 0.030 |
Why?
|
| STAT1 Transcription Factor | 1 | 2014 | 35 | 0.030 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2014 | 211 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2016 | 1448 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2014 | 944 | 0.020 |
Why?
|
| Biolistics | 1 | 2009 | 4 | 0.020 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2009 | 64 | 0.020 |
Why?
|
| DNA, Complementary | 1 | 2009 | 166 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2016 | 3190 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2009 | 396 | 0.020 |
Why?
|
| Computational Biology | 1 | 2009 | 325 | 0.020 |
Why?
|
| Binding Sites | 1 | 2009 | 875 | 0.020 |
Why?
|
| Base Sequence | 1 | 2009 | 1312 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2009 | 1977 | 0.020 |
Why?
|
| Caenorhabditis elegans | 1 | 2009 | 618 | 0.010 |
Why?
|